13.25
전일 마감가:
$13.46
열려 있는:
$13.49
하루 거래량:
6,652
Relative Volume:
0.23
시가총액:
$262.72M
수익:
$445.10M
순이익/손실:
$16.98M
주가수익비율:
15.06
EPS:
0.88
순현금흐름:
$12.69M
1주 성능:
-9.06%
1개월 성능:
-8.68%
6개월 성능:
-5.76%
1년 성능:
-32.47%
Natures Sunshine Products Inc Stock (NATR) Company Profile
명칭
Natures Sunshine Products Inc
전화
(801) 341-7900
주소
2901 WEST BLUEGRASS BLVD., LEHI
NATR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
NATR
Natures Sunshine Products Inc
|
13.27 | 262.72M | 445.10M | 16.98M | 12.69M | 0.88 |
![]()
KHC
Kraft Heinz Co
|
30.23 | 36.98B | 25.85B | 2.74B | 3.02B | 2.26 |
![]()
GIS
General Mills Inc
|
59.56 | 33.00B | 19.90B | 2.60B | 2.80B | 4.60 |
![]()
K
Kellanova
|
82.27 | 28.11B | 12.75B | 1.34B | 1.13B | 3.87 |
![]()
MKC
Mccormick Co Inc
|
80.47 | 21.49B | 6.68B | 792.60M | 774.40M | 2.94 |
![]()
HRL
Hormel Foods Corp
|
29.54 | 16.31B | 11.92B | 805.04M | 1.01B | 1.46 |
Natures Sunshine Products Inc Stock (NATR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-09-13 | 개시 | Canaccord Genuity | Buy |
2021-10-15 | 개시 | DA Davidson | Buy |
2015-04-09 | 개시 | Imperial Capital | In-line |
2014-06-02 | 개시 | Singular Research | Buy |
2013-03-08 | 재확인 | Imperial Capital | In-line |
Natures Sunshine Products Inc 주식(NATR)의 최신 뉴스
Earnings Miss: Nature's Sunshine Products, Inc. Missed EPS By 38% And Analysts Are Revising Their Forecasts - Yahoo Finance
With 45% ownership, Nature's Sunshine Products, Inc. (NASDAQ:NATR) has piqued the interest of institutional investors - Yahoo Finance
Proficio Capital Partners LLC Invests $200,000 in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Nature’s Sunshine Reports Record Revenue in Q4 and Full Year 2024 - Direct Selling News
Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q4 2024 Earnings Call Transcript - Insider Monkey
Natures Sunshine Products Inc (NATR) Q4 2024 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance UK
Natures Sunshine Products Inc (NATR) Q4 2024 Earnings Call Highl - GuruFocus.com
Earnings call transcript: Nature’s Sunshine Q4 2024 beats revenue forecast By Investing.com - Investing.com South Africa
Nature’s Sunshine Reports Growth Amid Challenges - TipRanks
Nature's Sunshine: Q4 Earnings Snapshot - mySA
Earnings call transcript: Nature’s Sunshine Q4 2024 beats revenue forecast - Investing.com
NATURES SUNSHINE PRODUCTS INC SEC 10-K Report - TradingView
Nature's Sunshine Products Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Nature's Sunshine Products Reports Q4 Breakeven, Net Sales Rise; 2025 Outlook Set - Marketscreener.com
Nature’s Sunshine Products posts mixed Q4 results By Investing.com - Investing.com Australia
Nature’s Sunshine Products posts mixed Q4 results - Investing.com
Nature's Sunshine (NASDAQ:NATR) Beats Q4 Sales Targets - Financial Content
Nature's Sunshine Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Nature’s Sunshine Products Announces Executive Salary Increases - TipRanks
Earnings To Watch: Nature's Sunshine (NATR) Reports Q4 Results Tomorrow - Yahoo Finance
Nature’s Sunshine Products (NATR) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Nature's Sunshine Products Inc expected to post earnings of 20 cents a shareEarnings Preview - TradingView
Nature's Sunshine Products, Inc. to Host Earnings Call - ACCESS Newswire
New York State Common Retirement Fund Has $76,000 Stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Nature’s Sunshine Products (NASDAQ:NATR) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Nature’s Sunshine Launches First Integrated Brand Platform - GlobeNewswire
How Nature's Sunshine's New "Be More Earth" Platform Could Reshape Natural Health Marketing - StockTitan
When the Price of (NATR) Talks, People Listen - Stock Traders Daily
Nature's Sunshine to Present at the 10th Annual Gateway Conference on September 9, 2021 - ACCESS Newswire
John Marshall Bancorp And 2 Other Undiscovered Gems In The US Market - Simply Wall St
Nature’s Sunshine Sets Fourth Quarter and Full Year 2024 - GlobeNewswire
Nature's Sunshine Sets Fourth Quarter and Full Year 2024 Conference Call for Tuesday, March 11, 2025, at 5:00 p.m. ET - The Manila Times
Nature's Sunshine Products to Host Conference Call on March 11, 2025, for Q4 and Full Year 2024 Financial Results - Nasdaq
Nature's Sunshine to Reveal Full Year 2024 Performance: What's Next for the Wellness Company? - StockTitan
Nature's Sunshine Products, Inc. (NASDAQ:NATR) Short Interest Down 17.5% in January - MarketBeat
(NATR) On The My Stocks Page - Stock Traders Daily
Nature's Sunshine Products (NASDAQ:NATR) Stock Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Short Interest Down 17.5% in January - Defense World
Nature’s Sunshine Products (NASDAQ:NATR) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Alkermes (ALKS) Stock Surges Over 5% Amid Positive Financials an - GuruFocus.com
Is It Time To Consider Buying Nature's Sunshine Products, Inc. (NASDAQ:NATR)? - Yahoo Finance
Nature's Sunshine Products (NASDAQ:NATR) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Katie A. May - Direct Selling News
Nature’s Sunshine Appoints Katie A. May to Board of Directors - GlobeNewswire
Nature’s Sunshine Appoints Katie May to Board - TipRanks
Nature’s Sunshine Appoints Katie A. May to Board of Directors | Daily Guardian - Daily Guardian Canada
Nature's Sunshine Appoints Katie A. May to Board of Directors - The Manila Times
Nature’s Sunshine Appoints Katie A. May to Board of Directors -February 05, 2025 at 04:06 pm EST - Marketscreener.com
Infant Vitamin Supplements Market to Exhibit a Remarkable CAGR - openPR
Natures Sunshine Products Inc (NATR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Natures Sunshine Products Inc 주식 (NATR) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 10 '24 |
Sale |
13.39 |
3,000 |
40,170 |
69,347 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 09 '24 |
Sale |
13.36 |
1,816 |
24,262 |
72,347 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 08 '24 |
Sale |
13.13 |
1,800 |
23,634 |
74,163 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 11 '24 |
Sale |
13.37 |
1,580 |
21,125 |
67,767 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 01 '24 |
Sale |
13.54 |
1,399 |
18,942 |
75,963 |
Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 14 '24 |
Sale |
13.12 |
1,300 |
17,056 |
66,467 |
Yates Bryant J | EVP & President, Europe |
Jun 06 '24 |
Sale |
15.30 |
3,068 |
46,940 |
98,852 |
자본화:
|
볼륨(24시간):